
[ Tue, Jul 29th ]: Metro
[ Tue, Jul 29th ]: Florida Today
[ Tue, Jul 29th ]: Forbes
[ Tue, Jul 29th ]: KOAT Albuquerque

[ Mon, Jul 28th ]: MinnPost
[ Mon, Jul 28th ]: WSB Cox articles
[ Mon, Jul 28th ]: WJTV Jackson
[ Mon, Jul 28th ]: abc13
[ Mon, Jul 28th ]: KRQE Albuquerque
[ Mon, Jul 28th ]: The Motley Fool
[ Mon, Jul 28th ]: WSAZ
[ Mon, Jul 28th ]: BGR
[ Mon, Jul 28th ]: WTVO Rockford
[ Mon, Jul 28th ]: Seeking Alpha
[ Mon, Jul 28th ]: Jerusalem Post
[ Mon, Jul 28th ]: ScienceAlert
[ Mon, Jul 28th ]: Fox News
[ Mon, Jul 28th ]: Associated Press
[ Mon, Jul 28th ]: The Jerusalem Post Blogs
[ Mon, Jul 28th ]: Cleveland.com
[ Mon, Jul 28th ]: CBS News
[ Mon, Jul 28th ]: The Globe and Mail
[ Mon, Jul 28th ]: Organic Authority
[ Mon, Jul 28th ]: Wrestle Zone
[ Mon, Jul 28th ]: gizmodo.com
[ Mon, Jul 28th ]: Fadeaway World
[ Mon, Jul 28th ]: The Weather Channel
[ Mon, Jul 28th ]: The New York Times
[ Mon, Jul 28th ]: Phys.org
[ Mon, Jul 28th ]: yahoo.com
[ Mon, Jul 28th ]: The Cool Down
[ Mon, Jul 28th ]: Forbes
[ Mon, Jul 28th ]: Chicago Tribune
[ Mon, Jul 28th ]: KCBD
[ Mon, Jul 28th ]: Impacts
[ Mon, Jul 28th ]: World Socialist Web Site
[ Mon, Jul 28th ]: IBTimes UK

[ Sun, Jul 27th ]: The New Indian Express
[ Sun, Jul 27th ]: Local 12 WKRC Cincinnati
[ Sun, Jul 27th ]: The Telegraph
[ Sun, Jul 27th ]: Good Housekeeping
[ Sun, Jul 27th ]: GovCon Wire
[ Sun, Jul 27th ]: The Jerusalem Post Blogs
[ Sun, Jul 27th ]: Forbes
[ Sun, Jul 27th ]: The Financial Express

[ Sat, Jul 26th ]: Reuters
[ Sat, Jul 26th ]: The News International
[ Sat, Jul 26th ]: KTVU
[ Sat, Jul 26th ]: Forbes
[ Sat, Jul 26th ]: Futurism
[ Sat, Jul 26th ]: lbbonline
[ Sat, Jul 26th ]: Phys.org
[ Sat, Jul 26th ]: NJ.com
[ Sat, Jul 26th ]: The Cool Down
[ Sat, Jul 26th ]: HuffPost Life
[ Sat, Jul 26th ]: The Jerusalem Post Blogs
[ Sat, Jul 26th ]: Live Science
[ Sat, Jul 26th ]: The Motley Fool
[ Sat, Jul 26th ]: thedispatch.com
[ Sat, Jul 26th ]: Salon
[ Sat, Jul 26th ]: WTVO Rockford
[ Sat, Jul 26th ]: yahoo.com
[ Sat, Jul 26th ]: ZDNet
[ Sat, Jul 26th ]: Impacts
[ Sat, Jul 26th ]: BBC
[ Sat, Jul 26th ]: Seeking Alpha
[ Sat, Jul 26th ]: The Globe and Mail
[ Sat, Jul 26th ]: London Evening Standard
[ Sat, Jul 26th ]: The New Indian Express

[ Fri, Jul 25th ]: NBC Washington
[ Fri, Jul 25th ]: 13abc
[ Fri, Jul 25th ]: CBS News
[ Fri, Jul 25th ]: The Observer, La Grande, Ore.
[ Fri, Jul 25th ]: reuters.com
[ Fri, Jul 25th ]: Upper
[ Fri, Jul 25th ]: Investopedia
[ Fri, Jul 25th ]: Ghanaweb.com
[ Fri, Jul 25th ]: Associated Press
[ Fri, Jul 25th ]: The Motley Fool
[ Fri, Jul 25th ]: Cleveland.com
[ Fri, Jul 25th ]: Newsweek
[ Fri, Jul 25th ]: KOAT Albuquerque
[ Fri, Jul 25th ]: The Cool Down
[ Fri, Jul 25th ]: Fox News
[ Fri, Jul 25th ]: Space.com
[ Fri, Jul 25th ]: Forbes
[ Fri, Jul 25th ]: Fortune
[ Fri, Jul 25th ]: The Boston Globe
[ Fri, Jul 25th ]: Leader-Telegram, Eau Claire, Wis.
[ Fri, Jul 25th ]: Madrid Universal
[ Fri, Jul 25th ]: moneycontrol.com
[ Fri, Jul 25th ]: Impacts
[ Fri, Jul 25th ]: Daily Record
[ Fri, Jul 25th ]: newsbytesapp.com

[ Thu, Jul 24th ]: WABI-TV
[ Thu, Jul 24th ]: WAFF
[ Thu, Jul 24th ]: HELLO! Magazine
[ Thu, Jul 24th ]: St. Louis Post-Dispatch
[ Thu, Jul 24th ]: thetimes.com
[ Thu, Jul 24th ]: Impacts
[ Thu, Jul 24th ]: The Hill
[ Thu, Jul 24th ]: Action News Jax
[ Thu, Jul 24th ]: Fox News
[ Thu, Jul 24th ]: NBC 6 South Florida
[ Thu, Jul 24th ]: Live Science
[ Thu, Jul 24th ]: sportskeeda.com
[ Thu, Jul 24th ]: Defense News
[ Thu, Jul 24th ]: Seeking Alpha
[ Thu, Jul 24th ]: CNET
[ Thu, Jul 24th ]: yahoo.com
[ Thu, Jul 24th ]: London Evening Standard
[ Thu, Jul 24th ]: The 74
[ Thu, Jul 24th ]: Ukrayinska Pravda
[ Thu, Jul 24th ]: Rhode Island Current
[ Thu, Jul 24th ]: The Decatur Daily, Ala.
[ Thu, Jul 24th ]: Foreign Policy
[ Thu, Jul 24th ]: Florida Today
[ Thu, Jul 24th ]: MassLive
[ Thu, Jul 24th ]: Business Today
[ Thu, Jul 24th ]: The Cool Down
[ Thu, Jul 24th ]: WFXT
[ Thu, Jul 24th ]: Newsweek
[ Thu, Jul 24th ]: Associated Press Finance
[ Thu, Jul 24th ]: Milwaukee Journal Sentinel
[ Thu, Jul 24th ]: The Straits Times
[ Thu, Jul 24th ]: The Sun
[ Thu, Jul 24th ]: newsbytesapp.com
[ Thu, Jul 24th ]: Forbes
[ Thu, Jul 24th ]: BBC
[ Thu, Jul 24th ]: WFTV
[ Thu, Jul 24th ]: TechCrunch
[ Thu, Jul 24th ]: The Michigan Daily
[ Thu, Jul 24th ]: moneycontrol.com

[ Wed, Jul 23rd ]: People
[ Wed, Jul 23rd ]: Today
[ Wed, Jul 23rd ]: ABC News
[ Wed, Jul 23rd ]: WESH
[ Wed, Jul 23rd ]: ABC
[ Wed, Jul 23rd ]: Seeking Alpha
[ Wed, Jul 23rd ]: Politico
[ Wed, Jul 23rd ]: yahoo.com
[ Wed, Jul 23rd ]: Atlanta Journal-Constitution
[ Wed, Jul 23rd ]: The Motley Fool
[ Wed, Jul 23rd ]: reuters.com
[ Wed, Jul 23rd ]: Telangana Today
[ Wed, Jul 23rd ]: Fox News
[ Wed, Jul 23rd ]: Newsweek
[ Wed, Jul 23rd ]: Medscape
[ Wed, Jul 23rd ]: The Scotsman
[ Wed, Jul 23rd ]: Deseret News
[ Wed, Jul 23rd ]: Forbes
[ Wed, Jul 23rd ]: KWCH
[ Wed, Jul 23rd ]: ThePrint
[ Wed, Jul 23rd ]: New Jersey Monitor
[ Wed, Jul 23rd ]: moneycontrol.com
[ Wed, Jul 23rd ]: Milwaukee Journal Sentinel
[ Wed, Jul 23rd ]: Daily Express

[ Tue, Jul 22nd ]: Fox 13
[ Tue, Jul 22nd ]: newsbytesapp.com
[ Tue, Jul 22nd ]: CNBC
[ Tue, Jul 22nd ]: Forbes
[ Tue, Jul 22nd ]: The Hill
[ Tue, Jul 22nd ]: KBTX
[ Tue, Jul 22nd ]: Detroit News
[ Tue, Jul 22nd ]: Fox News
[ Tue, Jul 22nd ]: The Independent
[ Tue, Jul 22nd ]: NBC DFW
[ Tue, Jul 22nd ]: Phys.org
[ Tue, Jul 22nd ]: Post-Bulletin, Rochester, Minn.
[ Tue, Jul 22nd ]: STAT
[ Tue, Jul 22nd ]: Associated Press
[ Tue, Jul 22nd ]: Newsweek
[ Tue, Jul 22nd ]: Space.com
[ Tue, Jul 22nd ]: Channel 3000
[ Tue, Jul 22nd ]: Tacoma News Tribune
[ Tue, Jul 22nd ]: The 74
[ Tue, Jul 22nd ]: Orlando Sentinel
[ Tue, Jul 22nd ]: Auburn Citizen
[ Tue, Jul 22nd ]: Impacts
[ Tue, Jul 22nd ]: BBC

[ Mon, Jul 21st ]: AFP
[ Mon, Jul 21st ]: ESPN
[ Mon, Jul 21st ]: al.com
[ Mon, Jul 21st ]: Forbes
[ Mon, Jul 21st ]: WFRV Green Bay
[ Mon, Jul 21st ]: Organic Authority
[ Mon, Jul 21st ]: Fox News
[ Mon, Jul 21st ]: gadgets360
[ Mon, Jul 21st ]: CNN
[ Mon, Jul 21st ]: USA TODAY
[ Mon, Jul 21st ]: NBC New York
[ Mon, Jul 21st ]: CBS News
[ Mon, Jul 21st ]: Seeking Alpha
[ Mon, Jul 21st ]: NJ.com
[ Mon, Jul 21st ]: Reuters
[ Mon, Jul 21st ]: Stateline
[ Mon, Jul 21st ]: Philadelphia Inquirer

[ Sun, Jul 20th ]: ABC
[ Sun, Jul 20th ]: The New Indian Express
Breakthrough in science: UCF chemists develop life-saving wound sealant


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
University of Central Florida researchers have developed SilFoam, a new foam-based treatment to stop severe bleeding.

UCF Chemists Unveil Revolutionary Wound Sealant: A Lifesaver for Battlefield and Emergency Care
In a groundbreaking advancement that could transform emergency medical treatment, chemists at the University of Central Florida (UCF) have developed an innovative wound sealant capable of stopping severe bleeding in mere seconds. This new technology, born from years of meticulous research in polymer chemistry and biomaterials, promises to save countless lives in high-stakes scenarios such as combat zones, car accidents, and surgical procedures. The sealant, which mimics natural clotting processes while enhancing them with cutting-edge science, represents a significant leap forward in trauma care, addressing one of medicine's most persistent challenges: rapid hemorrhage control.
The development stems from the UCF Department of Chemistry, where a team led by Associate Professor Kausik Mukhopadhyay has been pioneering solutions to uncontrolled bleeding. Hemorrhage remains a leading cause of preventable death in both military and civilian settings. According to medical experts, excessive blood loss can lead to shock, organ failure, and death within minutes if not addressed promptly. Traditional methods, such as applying pressure, using tourniquets, or administering clotting agents, often fall short in chaotic environments where time is critical and resources are limited. Mukhopadhyay's team sought to create a sealant that is not only fast-acting but also biocompatible, easy to apply, and effective on irregular wounds.
At the heart of this innovation is a specially engineered hydrogel—a gel-like substance composed of water-absorbing polymers. What sets this hydrogel apart is its unique formulation, which incorporates charged nanoparticles and bioactive molecules designed to interact rapidly with blood components. When applied to a wound, the sealant forms a robust, flexible barrier that adheres to the tissue almost instantly. Unlike conventional sealants that might require drying time or external activation, this one activates upon contact with blood, triggering a cascade of reactions that promote clotting and seal the breach. In laboratory tests, the material has demonstrated the ability to halt bleeding from simulated arterial injuries in under 10 seconds, a feat that could drastically reduce mortality rates.
Mukhopadhyay explains the science behind it: "We've drawn inspiration from how the body naturally responds to injury. Platelets and proteins in our blood work together to form clots, but in severe trauma, this process can be overwhelmed. Our sealant amplifies that natural mechanism by providing a scaffold that accelerates aggregation and stabilization." The hydrogel's composition includes polyethylene glycol (PEG) derivatives combined with chitosan, a natural polymer derived from crustacean shells, known for its hemostatic properties. These elements are fine-tuned at the molecular level to ensure the sealant is non-toxic, biodegradable, and resistant to infection. Early experiments on animal models have shown promising results, with wounds healing faster and with less scarring compared to untreated controls.
The potential applications of this wound sealant extend far beyond the laboratory. In military contexts, where soldiers face improvised explosive devices (IEDs) and gunshot wounds, quick intervention is paramount. The U.S. Department of Defense has long invested in technologies to improve battlefield medicine, and innovations like this could integrate seamlessly into medics' kits. Imagine a soldier applying a small packet of gel to a comrade's injury amid gunfire, buying precious time until evacuation. Civilian uses are equally compelling: paramedics responding to car crashes, surgeons managing intraoperative bleeding, or even first responders at mass casualty events could benefit. In rural or underserved areas, where access to advanced medical facilities is limited, such a tool could mean the difference between life and death.
To understand the broader impact, it's worth delving into the history of wound care innovations. For centuries, humans have relied on rudimentary methods like bandages and herbal poultices. The 20th century brought advancements such as fibrin glues and cyanoacrylate-based super glues, but these often come with drawbacks like toxicity, inflexibility, or failure in wet environments. More recent developments, including hemostatic foams and powders, have improved outcomes, but they can be messy, require precise application, and sometimes cause allergic reactions. UCF's sealant aims to overcome these limitations by being user-friendly—it's dispensed from a syringe or spray, conforms to any wound shape, and remains stable even in humid or bloody conditions.
The research process was no small feat. Mukhopadhyay's team spent over five years iterating on prototypes, conducting hundreds of experiments to optimize the gel's viscosity, adhesion strength, and degradation rate. They collaborated with biomedical engineers and trauma specialists to simulate real-world scenarios, using advanced models that replicate human tissue and blood flow. One key challenge was ensuring the sealant doesn't interfere with the body's healing process. "We had to balance rapid action with long-term biocompatibility," Mukhopadhyay notes. "Too sticky, and it might damage surrounding tissue; too weak, and it fails under pressure." Through rigorous testing, including in vitro assays and in vivo trials on rodents, the team refined the formula to achieve an ideal equilibrium.
Looking ahead, the UCF researchers are optimistic about clinical translation. They plan to partner with medical device companies to scale up production and pursue regulatory approval from the Food and Drug Administration (FDA). Initial human trials could begin within the next two to three years, focusing on safety and efficacy in controlled settings. If successful, the sealant could hit the market as a standalone product or be incorporated into existing trauma kits. Beyond immediate wound sealing, the technology holds promise for related fields, such as drug delivery systems where the hydrogel could release antibiotics or pain relievers directly at the injury site.
This breakthrough also highlights the vital role of academic institutions in driving scientific progress. UCF, known for its strong programs in optics, materials science, and now chemistry, is positioning itself as a hub for life-saving innovations. Funding from grants, including those from the National Science Foundation and the Department of Defense, has been instrumental in supporting this work. As Mukhopadhyay reflects, "Science isn't just about discovery; it's about making a tangible difference in people's lives. Every time we see our sealant work in the lab, we think of the soldiers, the accident victims, the patients who could benefit."
Critics and experts alike are watching closely. Some in the medical community caution that while lab results are encouraging, real-world variables like varying wound types, patient conditions, and environmental factors must be thoroughly tested. Nonetheless, the enthusiasm is palpable. Dr. Elena Ramirez, a trauma surgeon not affiliated with the project, commented, "If this sealant performs as described, it could revolutionize how we approach bleeding control. It's the kind of innovation that reminds us why we push the boundaries of science."
In an era where medical advancements are accelerating, UCF's wound sealant stands out as a beacon of hope. It underscores the power of interdisciplinary collaboration—blending chemistry, biology, and engineering to solve pressing human problems. As the team continues to refine and expand their work, the world may soon witness a new standard in emergency care, one that seals wounds not just physically, but also the gaps in our ability to save lives under duress. This development is more than a scientific achievement; it's a testament to human ingenuity in the face of adversity, potentially sparing families the grief of preventable loss and giving heroes on the front lines a fighting chance. With further validation and adoption, this humble gel could become an indispensable tool in the global fight against trauma-induced mortality.
Read the Full Fox 13 Article at:
[ https://www.fox13news.com/news/breakthrough-science-ucf-chemists-develop-life-saving-wound-sealant ]